China sets up first CML molecular testing platform
Updated: 2013-02-20 20:16
By Shan Juan (chinadaily.com.cn)
|
|||||||||||
The first-ever standardized molecular testing platform for chronic myelogenous leukemia has been set up on the Chinese mainland to help facilitate accurate diagnosis and drug therapy.
CML is a cancer of the white blood cells, according to medical experts. It is a form of leukemia characterized by the increased and unregulated growth of predominantly myeloid cells in the bone marrow and the accumulation of these cells in the blood.
Of all adult leukemia cases in China, CML accounts for between 15 and 20 percent, and most of the patients are around 50 years old, according to statistics from the Ministry of Health.
"Given that molecular monitoring matters a lot to effective CML treatment, the latest platform now comprising 10 major hospitals across the mainland will help standardize the testing method, enhance its accuracy and improve the treatment of the cancer," said professor Huang Xiaojun of the Peking University People's Hospital, who heads the hospital's Institute of Hematology.
Molecular testing results at one hospital couldn't be recognized by others due to varied testing methods, Huang said.
He said the platform would help standardize the testing, and the results would be used by all partner hospitals.
"That could help prevent repeated testing for patients," he added. The testing costs about 500 yuan ($80) to 600 yuan ($96).
He also expects that another 10 hospitals will be covered by the platform within the year.
Related Stories
Hunan offers subsidy to leukemia patients 2012-11-07 16:27
Today's Top News
Police continue manhunt for 2nd bombing suspect
H7N9 flu transmission studied
8% growth predicted for Q2
Nuke reactor gets foreign contract
First couple on Time's list of most influential
'Green' awareness levels drop in Beijing
Palace Museum spruces up
Trading channels 'need to broaden'
Hot Topics
Lunar probe , China growth forecasts, Emission rules get tougher, China seen through 'colored lens', International board,
Editor's Picks
Liaoning: China's oceangoing giant |
Poultry industry under pressure |
'Spring' in the air for NGOs? |
Boy set to drive Chinese golf |
Latest technology gets people talking |
Firms crave cyber connection |